T1	OrganismPart 0 5	Brain
T2	Modification 6 12	ureido
T4	Disease 68 85	neuroinflammation
T5	Disease 90 103	proteinopathy
T6	Disease 107 155	Alzheimer's disease with cerebrovascular disease
T7	FractionationMethod 1012 1094	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T8	FractionationMethod 1096 1104	UC-ERLIC
*	Equiv T7 T8
T11	Disease 304 352	Alzheimer's disease with cerebrovascular disease
T12	Disease 354 362	AD + CVD
*	Equiv T11 T12
T15	Modification 730 753	arginine citrullination
T16	Modification 758 778	lysine carbamylation
T17	FractionationFraction 1203 1210	soluble
T18	FractionationFraction 1215 1226	particulate
T19	Disease 1281 1289	AD + CVD
T20	Disease 1294 1314	age-matched controls
T21	Disease 2706 2725	Alzheimer's disease
T22	Disease 2727 2729	AD
*	Equiv T21 T22
T23	Disease 2828 2851	Cerebrovascular disease
T24	Disease 2853 2856	CVD
*	Equiv T23 T24
T3	Modification 3508 3522	citrullination
T9	Modification 3527 3540	carbamylation
T10	Modification 3770 3793	Carbamylation of lysine
T13	Modification 4277 4291	Citrullination
T14	Modification 4461 4474	carbamylation
T25	Disease 8288 8296	AD + CVD
T26	Disease 8301 8328	healthy age-matched control
T27	Disease 8330 8334	Ctrl
*	Equiv T26 T27
T28	Organism 8346 8351	human
T29	OrganismPart 8352 8357	brain
T30	OrganismPart 8367 8387	middle temporal lobe
T31	OrganismPart 8389 8400	BA21 region
T32	SupplementaryFile 8747 8755	Table S1
T33	NumberOfBiologicalReplicates 8757 8762	Three
T34	FractionationFraction 8860 8867	soluble
T35	FractionationFraction 8872 8883	particulate
T36	FractionationMethod 10334 10342	UC-ERLIC
T37	FractionationMethod 10423 10505	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T38	FractionationMethod 10507 10515	UC-ERLIC
*	Equiv T37 T38
T39	FractionationFraction 11050 11057	soluble
T40	FractionationFraction 11330 11341	particulate
T41	AlkylationReagent 11744 11757	iodoacetamide
T42	ReductionReagent 11658 11672	dithiothreitol
T43	ReductionReagent 11674 11677	DTT
*	Equiv T42 T43
T44	CleavageAgent 12063 12070	trypsin
T45	CleavageAgent 13932 13939	trypsin
T46	FractionationMethod 14445 14459;14517 14548	PolyWAX column Shimadzu Prominence UFLC system
T47	Instrument 15295 15309	Orbitrap Elite
T48	Separation 15343 15376	Dionex UltiMate 3000 UHPLC system
T49	Separation 15485 15524	reverse phase Acclaim PepMap RSL column
T50	GradientTime 15690 15696	60-min
T51	FragmentationMethod 16799 16835	high-energy collisional dissociation
T52	FragmentationMethod 16837 16840	HCD
*	Equiv T51 T52
T53	IonizationType 16203 16219	nanoelectrospray
T54	Instrument 16297 16311	Orbitrap Elite
T55	MS2MassAnalyzer 16624 16632	FT-MS/MS
T56	FactorValue 8288 8296	AD + CVD
T57	FactorValue 8301 8328	healthy age-matched control
